Bank of South Carolina Q3 net income rises 13% to $2.42 million; net interest margin widens 55 bps to 4.85%
Bitget2026/10/08 13:03Bank of South Carolina posted Q3 net income of $2.42 million, up 13% from the year-earlier quarter. Diluted EPS climbed 16% to $0.44 versus the year-earlier quarter, while annualized return on average assets improved to 1.71%. Net interest margin widened to 4.85% from 4.30% a year earlier, and the efficiency ratio edged down to 53.20%. Loans past due more than 30 days rose to 0.28% from 0.21% a year earlier, while the community bank leverage ratio increased to 11.93%. CEO Eugene H. Walpole IV cited steady local loan demand, a solid capital position, and low past-due loans heading into year-end. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bank of South Carolina Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610080900PR_NEWS_USPR_____CL66224) on October 08, 2026, and is solely responsible for the information contained therein.
- Bank of South Carolina posted Q3 net income of $2.42 million, up 13% from the year-earlier quarter.
- Diluted EPS climbed 16% to $0.44 versus the year-earlier quarter, while annualized return on average assets improved to 1.71%.
- Net interest margin widened to 4.85% from 4.30% a year earlier, and the efficiency ratio edged down to 53.20%.
- Loans past due more than 30 days rose to 0.28% from 0.21% a year earlier, while the community bank leverage ratio increased to 11.93%.
- CEO Eugene H. Walpole IV cited steady local loan demand, a solid capital position, and low past-due loans heading into year-end.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
